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Volume 51, Number 11S Abstracts 87SAneuRx and Cook Zenith). All five patients did well with no
postoperative bleeding and were discharged home in good
condition.
Conclusions: Endovascular repair of arterial injuries
offers a safe and less invasive alternative in patients with
these types of injuries.
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Derivation and Validation of a Practical Risk Score for
Mortality After Repair of Ruptured Abdominal Aortic
Aneurysms and Comparison to Existing Models in a
U. S. Regional Cohort
WilliamP.Robinson1, Andres Schanzer1, YoufuLi3, BrianW.
Nolan2, Philip P. Goodney2, Mohammad H. Eslami1, Louis
Messina1, Jack L. Cronenwett2. 1Division of Vascular and
Endovascular Surgery, University of Massachusetts Medical
School, Worcester, MA; 2Division of Vascular and Endovas-
cular Surgery, Dartmouth-Hitchcock Medical Center, Leba-
non, NH; 3Department of Surgery, University of Massachu-
setts Medical School, Worcester, MA
Objectives: Published models for predicting mortality
after repair of ruptured abdominal aortic aneurysms (rAAA)
have not been tested in the United States. Using prospec-
tively-collected data from the Vascular Study Group of
New England (VS GNE), we aimed to develop a practical
risk score for in-hospital mortality after repair of rAAA and
compare it to the Glasgow Aneurysm Score, Hardman
Index, and Vancouver Score.
Methods: 242 patients underwent open repair of
RAAA at 11 centers from 2003-2009. The VS GNE cohort
was randomized to a derivation (n  164) and validation
set (n  78). Significant predictors of mortality on multi-
variable regression were assigned integer weights to gener-
ate a total risk score which was tested in the validation set.
Discrimination and calibration of all models were assessed
via area under the receiver-operator curve (c-statistic) and
Hosmer-Lemeshow test.
Results: In-hospital mortality was 37% (n  88).
Age76 (OR 5.3, 95% CI 2.8-10.1), cardiac arrest (OR 4.3,
95% CI 1.6-12), loss of consciousness (OR 2.6, 95% CI
1.2-6), and suprarenal aortic clamp (OR2.4, 95%CI 1.3-4.6)
were independently associatedwithmortality. Integerweights
derived from the odds ratios were used to derive a total risk
score (range 0-6) which accurately predicted mortality risk
(9%, 20%, 42%, 60%, and 79% for scores of 0, 1, 2, 3, and 4
respectively). Discrimination and calibration were excellent in
the derivation (c  .79) and validation (c  .75) sets (p 
0.0001). GAS (c  .75), Hardman Index (c  .72), and
Vancouver Score (c .76) predicted mortality (p 0.0001)
but less easily identified patients at highest risk of mortality.Conclusions: Existing models predict mortality after
rAAA repair in this cohort but are limited in identification of
patients at highest risk. This parsimonious VS GNE risk score
based on four variables readily assessed in current practice
allows accurate prediction of in-hospital mortality after open
repair of rAAA.
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Jeffrey Jim, Brian G. Rubin, Patrick J. Geraghty, Luis A.
Sanchez. Division of Vascular Surgery, Washington Univer-
sity School of Medicine, St. Louis, MO
Objectives: To evaluate the outcomes of endovascular
repair of abdominal aortic aneurysm (EVAR) in patients
with small (5.5cm) abdominal aortic aneurysms (AAAs).
Methods: A total of 156 patients enrolled in the pro-
spective 5-year Talent eLPS trial were evaluated. Subgroup
analyses were performed for patients with small (5.5cm)
AAAs and larger (5.5cm) AAAs. Demographics, aneu-
rysm morphology and perioperative endpoints were as-
sessed. Safety and effectiveness endpoints were evaluated at
30 days, 1 year, and 5 years post procedure.
Results: Patients with small AAAs (n 85) had similar
age, gender, and medical risk profile compared to those
with larger AAAs (n  71). The proximal aortic neck in
small AAA patients was longer (24.7 mm vs 20.7 mm, p 
0.05), less angulated (27.20 vs 34.2o, p  0.01) and
smaller (24.6 mm vs 26.1 mm, p  0.01). Small AAA
patients spent less time in the ICU (8.1 h vs 26.3h, p 
0.03) but other perioperative endpoints were similar. The
small AAA group had a statistically significant higher rate of
successful aneurysm treatment (96.8% vs 84.9%, p  0.04)
but no difference in all other effectiveness endpoints at 12
months. There were no differences in freedom from major
adverse events (MAEs) at 30 days and 365 days. At five
years, there are no differences in rates ofmigration, endoleaks,
change in aneurysm diameter, or freedom from aneurysm-
related mortality. Further subgroup analyses separating very
small (5.0cm, n55), small (5.1-5.4cm, n30) and larger
(5.5cm)AAApatients also showedno statistically significant
differences in postoperative outcomes.
Conclusions: In a prospective clinical trial setting with
long-term follow-up, patients with small (5.5cm) AAAs
had a higher rate of successful aneurysm treatment. This
may be attributable to their more favorable aortic neck
anatomy. However, all other long-term outcome parame-
ters showed no difference compared to patients with larger
AAAs.
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Left Subclavian Artery Coverage During Endovascular
Thoracic Aortic Repair and Risk of Perioperative
Stroke or Death
Matthew A. Corriere, Jayer Chung, Karthikeshwar Kasira-
jan, Ravi Veeraswamy, Thomas F. Dodson, Atef A. Salam,
Elliot L. Chaikof. Surgery, Division of Vascular Surgery
and Endovascular Therapy, Emory University School of
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Objectives: Anatomic factors may dictate left subclavian
artery (LSA) coverage during endovascular thoracic aortic
repair (TEVAR); associations between LSA coverage, stroke,
and death are inconsistent in published reports. We examined
the 2005-2008 ACS-NSQIP data file to determine perioper-
ative risk of stroke or death after LSA coverage.
Methods: TEVAR procedures, LSA coverage, and
subclavian revascularization were identified by CPT codes.
Patients with simultaneous coronary, ascending or abdom-
inal aortic, or non-vascular abdominal procedures were
excluded. Associations between LSA coverage and 30-day
stroke and mortality were examined with logistic regres-
sion. Effects of subclavian revascularization with LSA cov-
erage were assessed with Fisher’s exact test.
Results: From 862 identified TEVAR procedures, 53
patients were excluded and 809 formed the basis of this
analysis. 279 procedures (38%) included LSA coverage;
subclavian revascularization was performed in 53 (7%).
30-day stroke and mortality rates were 5.2% and 7.1%. In
multivariate models, LSA coverage was associated with
perioperative stroke (OR 2.4; 95% CI 1.2-4.5; p  0.009)
and death (OR 1.9; 95% CI 1.0-3.6; p  0.042). Subcla-
vian revascularization was not associated with decreased
stroke or mortality in patients undergoing LSA coverage.
Conclusions: LSA coverage is associated with in-
creased risk of perioperative stroke and death; no protective
subclavian revascularization effect was observed.
Multivariate predictors of stroke and mortality.
Univariate p  0.10 for all displayed covariates.
Outcome Covariate OR (95% CI) P
Stroke Emergent procedure 3.10 (1.46-6.58) 0.003
Left subclavian artery coverage 2.36 (1.24-4.49) 0.009
Mortality Age (years) 1.46 (1.02-2.10) 0.041
WBC (1000/mL3) 1.35 (1.04-1.74) 0.024
Emergent procedure 2.23 (1.08-4.58) 0.030
Units PRBC transfused 1.26 (1.15-1.38) 0.001
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Sideways Movement of the Endograft Within the An-
eurysm Sac Is Associated With Late Adverse Events
Evert Waasdorp2, Madhu Gorrepati1, Frans Moll2, Chris-
topher Zarins1. 1Vascular Surgery, Stanford University
Medical Hospital, Stanford, CA; 2University Medical Cen-
ter Utrecht, Utrecht, Netherlands.
Objectives: Previous studies have shown the impor-
tance of proximal and distal endograft fixation. There is
little information on the middle, unsupported section of
the endograft. We have quantified sideways movement of
the endograft within the AAA sac and correlated it to late
adverse events.
Methods: Patients who underwent EVAR between
January 1997 and December 2007 were analyzed. Patients
with a digital available preoperative CT-angiography
(CTA), postoperative CTA and at least one follow-up CTA
thereafter were included. Changes in endograft position
within the AAA sac were measured. Patients with sideways
movement 5mm were placed in the movement group
(MG) and were compared with patients with no movement
(5mm, NM group). To analyze the association of side-
ways endograft movement and EVAR related complication
the following outcomemeasures were noted: AAA rupture,
AAA-related death, conversion, secondary procedures,
AAA growth (5mm), proximal migration (10mm), and
new onset type 1/3 endoleaks.
Results: 144 patients (mean age 76 year) were
included. Follow-up was 43  27 months. Fifty patients
(35%) had sideways endograft movement. AAA diameter
(MG 60  9 vs NM 57  9mm, p  0.05), and proximal
and iliac endograft fixation lengths were significantly differ-
ent between the groups (MG 18  8 vs NM 25  11mm,
p 0.05 and MG 35 15 vs NM 42 16mm, p 0.05).
There was no significant difference between the groups in
terms of AAA rupture and AAA-related death (one fatal
AAA rupture, NM group). Patients in the MG group had a
significantly higher conversion rate (14 vs 0%, p  0.001)
and had more secondary procedures (44 vs 6%, p 0.001).
Patients in the MG had significantly more AAA growth (42
vs 10%, p  0.001), more proximal migration (66 vs 5%,
p  0.001) and more often type 1/3 endoleaks (36 vs 3%,
p  0.001).
Conclusions: Sideways movement of the device within
the AAA sac is associated with late adverse events. Con-
